Literature DB >> 2919530

Controlled versus hyperemic flow during reperfusion of jeopardized ischemic myocardium.

C F Peng1, M L Murphy, K Colwell, K D Straub.   

Abstract

Controlled versus uncontrolled reperfusion of ischemic myocardium after experimental coronary artery occlusion was studied to determine the effect on regional ventricular wall motion and associated biochemical alterations. Fourteen pigs underwent coronary artery occlusion for 1 hour followed by 2 hours of reperfusion. In seven animals uncontrolled reperfusion was achieved by complete release of the arterial occlusion resulting in hyperemic flow. In seven other animals coronary flow during reperfusion was controlled at baseline levels eliminating hyperemic flow. Our results show that controlled reperfusion lessens end-diastolic wall thickness, reduces myocardial calcium deposition, increases the rate of mitochondrial oxidative phosphorylation, and preserves cellular high-energy phosphate stores in the ischemic-reperfused myocardium when compared to the uncontrolled reperfusion state. These data suggest that the magnitude of flow at an early stage of reperfusion is one of the important determinants in the outcome of ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2919530     DOI: 10.1016/0002-8703(89)90723-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Myocardial protection during surgical intervention for treatment of acute myocardial infarction.

Authors:  F Beyersdorf; G D Buckberg
Journal:  Tex Heart Inst J       Date:  1992

2.  Transfused older stored red blood cells improve the clinical course and outcome in a canine lethal hemorrhage and reperfusion model.

Authors:  Steven B Solomon; Irene Cortés-Puch; Junfeng Sun; Kenneth E Remy; Dong Wang; Jing Feng; Sameena S Khan; Derek Sinchar; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson
Journal:  Transfusion       Date:  2015-07-15       Impact factor: 3.157

3.  Protection of the ischemic myocardium during the reperfusion: between hope and reality.

Authors:  Jean Chrisostome Bopassa
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

Review 4.  Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.

Authors:  Demetria M Fischesser; Bin Bo; Rachel P Benton; Haili Su; Newsha Jahanpanah; Kevin J Haworth
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-17       Impact factor: 2.457

5.  Experiences in intravenous urokinase treatment of 100 acute myocardial infarction patients.

Authors:  H Y Zhao; H B Li; L Wang; X H Zheng; H Wu
Journal:  J Tongji Med Univ       Date:  1991

6.  A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion.

Authors:  Claudio A Bravo; Dorothy E Vatner; Ronald Pachon; Jie Zhang; Stephen F Vatner
Journal:  J Pharmacol Exp Ther       Date:  2016-03-03       Impact factor: 4.030

Review 7.  The role of capillary transit time heterogeneity in myocardial oxygenation and ischemic heart disease.

Authors:  Leif Ostergaard; Steen Buus Kristiansen; Hugo Angleys; Jørgen Frøkiær; J Michael Hasenkam; Sune Nørhøj Jespersen; Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2014-04-18       Impact factor: 17.165

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.